2m 2m 2m 2m 2m 2m 2m
Clever Leaves (CLVR)
OTC
$2.90+$2.90 (+289,999,900.00%)
Price as of May 23, 2024 11:34 AM EDT- $350.00Market Cap
- -99.67%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Clever Leaves (CLVR)
$2.90+$2.90 (+289,999,900.00%)
Annual
Quarterly
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 17.4M -2.15% | 17.8M +15.78% | 15.4M +26.88% | 12.1M N/A | |
Cost of Revenue | 10.9M -19.37% | 13.5M +57.27% | 8.6M +82.08% | 4.7M N/A | |
Gross Profit | 6.6M +51.41% | 4.3M -36.41% | 6.8M -8.15% | 7.4M N/A | |
Sales and Marketing Expense | 2.0M +7.33% | 1.9M -50.03% | 3.8M +47.30% | 2.6M N/A | |
Research and Development Expense | -1.1M -33.68% | -1.7M +11.19% | -1.5M N/A | N/A N/A | |
Depreciation and Amortization Expense | 2.4M -35.35% | 3.7M +4.68% | 3.5M -2.28% | 3.6M N/A | |
Total Operating Expenses | 22.1M -72.11% | 79.4M +24.08% | 64.0M +78.11% | 35.9M N/A | |
Operating Profit | -15.6M -79.24% | -75.1M +31.28% | -57.2M +100.53% | -28.5M N/A | |
Interest Income | -3.7M -45.44% | -6.9M N/A | 0 -100.00% | 464,000 N/A | |
Interest Expense | -46,000 +70.37% | -27,000 -96.32% | -733,000 +4.12% | -704,000 N/A | |
Interest Income and Expense and Net | -3.8M -44.98% | -6.9M +838.34% | -733,000 +205.42% | -240,000 N/A | |
Total Nonoperating Income and Expense | -4.1M +56.21% | -2.6M -78.87% | -12.5M +375.01% | -2.6M N/A | |
Income before Taxes | -19.7M -72.77% | -72.5M +62.16% | -44.7M +72.57% | -25.9M N/A | |
Income Taxes | 68,000 +101.07% | -6.4M -768.84% | 950,000 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | 0 N/A | 0 N/A | |
Net Income | -17.9M -72.95% | -66.2M +44.70% | -45.7M +76.58% | -25.9M N/A | |
Net Income from Continuing Operations Applicable to Common | -19.8M -70.08% | -66.2M +44.70% | -45.7M +76.61% | -25.9M N/A | |
Basic EPS and Net Income | -11.42 +563.95% | -1.72 -3.37% | -1.78 -46.71% | -3.34 N/A | |
Diluted EPS and Net Income | -11.42 +563.95% | -1.72 -3.37% | -1.78 -46.71% | -3.34 N/A | |
Basic Weighted Average Shares | 1.6M -95.92% | 38.4M +49.44% | 25.7M +137.53% | 10.8M N/A | |
Diluted Weighted Average Shares | 1.6M -95.92% | 38.4M +49.44% | 25.7M +137.53% | 10.8M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 6.8M -45.13% | 12.4M -66.56% | 37.2M -52.94% | 79.1M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 6.8M -45.13% | 12.4M -66.56% | 37.2M -52.94% | 79.1M N/A | |
Total Current Assets | 13.9M -46.89% | 26.2M -56.54% | 60.4M -36.96% | 95.8M N/A | |
Accumulated Depreciation | 8.8M +23.50% | 7.1M +24.87% | 5.7M +69.90% | 3.4M N/A | |
Property and Plant and Equipment and Net | 12.3M -20.32% | 15.5M -50.01% | 30.9M +20.45% | 25.7M N/A | |
Total Long-Term Assets | 0 -100.00% | 52,000 -80.00% | 260,000 +400.00% | 52,000 N/A | |
Total Assets | 31.2M -40.03% | 52.1M -55.15% | 116.2M -29.97% | 165.9M N/A | |
Income Taxes Payable | N/A N/A | 0 -100.00% | 6.7M +16.67% | 5.7M N/A | |
Total Short-Term Debt | N/A N/A | 0 -100.00% | 16.6M N/A | N/A N/A | |
Total Current Liabilities | 5.8M -38.35% | 9.4M -65.40% | 27.2M -6.78% | 29.2M N/A | |
Total Long-Term Debt | 2.2M N/A | 0 -100.00% | 1.1M -96.63% | 33.8M N/A | |
Total Long-Term Liabilities | 12,000 -89.29% | 112,000 -68.89% | 360,000 -48.05% | 693,000 N/A | |
Total Liabilities | 7.0M -39.90% | 11.7M -73.06% | 43.4M -38.57% | 70.6M N/A | |
Retained Earnings | -198.8M +9.89% | -180.9M +57.67% | -114.7M +66.26% | -69.0M N/A | |
Total Stockholders Equity | 24.2M -40.07% | 40.4M -44.47% | 72.8M -23.60% | 95.3M N/A | |
Total Shares Outstanding | 1.7M -96.04% | 43.6M +64.01% | 26.6M +6.92% | 24.9M N/A | |
Cash Flow | |||||
Cash from Operating Activities | -11.5M -60.41% | -29.1M -19.78% | -36.2M +64.99% | -22.0M N/A | |
Capital Expenditures | 31,000 -97.63% | 1.3M -82.06% | 7.3M +98.64% | 3.7M N/A | |
Cash from Investing Activities | 4.7M +293.79% | 1.2M +116.37% | -7.3M +98.64% | -3.7M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 656,000 -80.05% | 3.3M +79.33% | 1.8M -98.00% | 91.8M N/A | |
Financials Ratio | |||||
Gross Margin | 37.64% +54.74% | 24.33% -45.07% | 44.29% N/A | N/A N/A | |
Operating Margin | -89.53% -78.78% | -421.92% +13.39% | -372.10% N/A | N/A N/A | |
Return on Assets | -42.95% -45.38% | -78.65% +142.55% | -32.43% N/A | N/A N/A | |
Return on Equity | -55.39% -52.62% | -116.92% +114.81% | -54.43% N/A | N/A N/A | |
Revenue Growth | -2.15% -113.64% | 15.78% -41.29% | 26.88% N/A | N/A N/A | |
Current Ratio | 2.40 -13.85% | 2.78 +25.61% | 2.22 N/A | N/A N/A | |
Cash Ratio | 1.18 -10.99% | 1.32 -3.34% | 1.37 N/A | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | 0.00 -100.00% | 0.24 N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | 0.00 -100.00% | 0.15 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow